RecruitingNot ApplicableNCT04114799

Haemodynamical Optimization During Brain Surgery

A Comparison of Perioperative Fluid Management Using Invasive Haemodynamical Measurement of Fluid Responsiveness (Aisys GE) and Non-invasive Measurement of Haemodynamics (ClearSight System, Edwards) During Brain Surgery


Sponsor

University Hospital Hradec Kralove

Enrollment

50 participants

Start Date

Apr 1, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The decision to give fluids perioperatively could be based on methods used to identify preload responsiveness, either invasive or noninvasive estimates of stroke volume variation during mechanical ventilation. This study compares fluid management using invasive measurement SPV/PPV (Aisys GE) and noninvasive haemodynamic measurement (ClarSight, Edwards).


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Glasgow Coma scale 15
  • ASA Physical Status Classification System I-III
  • planed surgery for brain tumor to 5 hours
  • postoperative awakening
  • sinus rhythm

Exclusion Criteria4

  • NYHA III, IV
  • BMI over 40 in females and over 35 in men
  • awake operation
  • postoperative artificial ventilation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREHemodynamic management based on invasive fluid responsiveness parameters

In case of hypotension (reduction of MAP for more than 15% of individual blood pressure) the SPV value more than 8% will be used as a trigger for the bolus of 2 ml/kg of Plasmalyte (Baxter)

PROCEDUREHemodynamic management based on noninvasive cardiac output and SVV measurement

In case of hypotension (reduction of MAP for more than 15% of individual blood pressure) the systemic vascular resistance (SVR) value will be used to trigger norepinephrine infusion. In patients with low SVR norepinephrine infusion will be started. In patients with high SVR value either fluid bolus (in patient with SVV value above 8%), or dobutamine infusion (in patients with SVV value below or equal 8%) will be used.


Locations(1)

University Hospital Hradec Kralove

Hradec Králové, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04114799


Related Trials